No efficacy of processed Fabuless (Olibra) in suppressing appetite or food intake
- 22 September 2010
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 65 (1) , 81-86
Abstract
Background/Objectives: To investigate the feasibility of Fabuless (previously called Olibra and Reducal) as a food ingredient for food intake and appetite reduction, by assessing the effects of food processing on efficacy. Subjects/Methods: In total, 24 healthy volunteers (16 female, 8 male; age: 18–43 years; body mass index: 18–37 kg/m2) took part in a randomized, placebo-controlled, double-blinded, cross-over trial. Yoghurt-based meal replacement drinks (containing processed or unprocessed Fabuless, or a control fat) were followed by an ad libitum lunch and evening meal (dinner). Key outcome measures were energy intake and self-reported appetite ratings. Results: Compared with control, only unprocessed Fabuless reduced subsequent energy intake, although only during dinner (P<0.01; control, processed and unprocessed: 4.3, 3.9 and 4.2 MJ, respectively) and not during lunch (3.6, 3.7 and 3.6 MJ). Self-reported appetite scores did not differ between treatments. Conclusions: Although modest effects of unprocessed Fabuless were seen on food intake, but not on appetite, the ingredient was not robust to common food-manufacturing processes (thermal and shear processing). Claims on reduced food intake and appetite relating to this ingredient in food products are, therefore, only valid if functionality has been demonstrated after all relevant processing and storage steps.Keywords
This publication has 21 references indexed in Scilit:
- Effect of fat emulsion (Fabuless) on orocecal transit time in healthy menScandinavian Journal of Gastroenterology, 2009
- Short-term effects of a novel fat emulsion on appetite and food intakePhysiology & Behavior, 2008
- Investigation of the medium-term effects of Olibra™ fat emulsion on food intake in non-obese subjectsEuropean Journal of Clinical Nutrition, 2006
- Prolonged Gastrointestinal Transit in a Patient with a Glucagon-Like Peptide (GLP)-1- and -2-Producing Neuroendocrine TumorThe Journal of Clinical Endocrinology & Metabolism, 2002
- Dose–response effects of a novel fat emulsion (Olibra™) on energy and macronutrient intakes up to 36 h post-consumptionEuropean Journal of Clinical Nutrition, 2002
- The effects of yoghurt containing a novel fat emulsion on energy and macronutrient intakes in non-overweight, overweight and obese subjectsInternational Journal of Obesity, 2001
- Short-term effects of yoghurt containing a novel fat emulsion on energy and macronutrient intakes in non-obese subjectsInternational Journal of Obesity, 2000
- Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studiesInternational Journal of Obesity, 2000
- Original Articles Sibutramine Reduces Food Intake in Non‐Dieting Women with ObesityObesity Research, 1998
- Indirect gastrointestinal transit monitoring and absorption of theophyllineInternational Journal of Pharmaceutics, 1996